This trial is active, not recruiting.

Condition polycystic ovary syndrome
Treatments cinnamon extract, placebo
Phase phase 3
Sponsor Rogerio A. Lobo
Collaborator Integrity Nutraceuticals International
Start date March 2011
End date May 2013
Trial size 45 participants
Trial identifier NCT01483118, AAAI1377


The primary purpose of this follow-up study is to determine if cinnamon can restore menstrual cyclicity in Polycystic Ovary Syndrome (PCOS) subjects with oligomenorrhea. As a secondary purpose, the investigators intend to confirm the salutatory effect of cinnamon on insulin resistance in larger group of study subjects.

Polycystic ovary syndrome (PCOS) is a very common condition found in women of childbearing age. PCOS patients often have irregular periods, extra hair growth, or difficulty becoming pregnant. The syndrome can also be associated with more serious conditions such as heart disease, diabetes, or cancer of the uterus. Although no one knows the cause of the syndrome, scientific studies showed that having too much insulin can be one of the reasons. In fact, almost every overweight woman with PCOS has been found to have high insulin levels.

Recently studies using rats and mice have shown that a commonly used spice, cinnamon, may also reduce the body's insulin level. Another study showed that daily use of cinnamon for forty days lowered the blood sugar level in patients with diabetes. Our own study also showed that using cinnamon everyday for 8 weeks decreased insulin resistance in women with PCOS. The purpose of this study is to see if cinnamon can help women with PCOS have more regular periods.

All patients will eat a balanced diet containing 1800 calories per day, but half of the patients in the study will take pre-made cinnamon extract pills three times a day, while the other half will take placebo pills (pills with no cinnamon extract) three times a day for 6 months. During this time, every patient will keep track of her period on a calendar.

Blood tests measuring insulin, substances important for insulin action, cholesterol, and glucose (sugar) will be taken before and after the 6 months of medication. A total of 8 separate visits will be needed to finish the study. At the end of the study, the investigators will then compare the number of periods, blood glucose, insulin, and cholesterol levels between the patients that took cinnamon and the patients that took placebo.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (subject, investigator)
Primary purpose treatment
(Active Comparator)
Purified aqueous abstract of cinnamon in 125mg capsules
cinnamon extract Cinnulin PF
Purified aqueous abstract of cinnamon in 125mg capsules, which would be taken orally before each meal, for a total of 1,500mg/day for 6 months.
(Placebo Comparator)
Placebo capsules containing ground cereal.
Placebo capsules containing ground cereal.

Primary Outcomes

Number of menses during the six month study period.
time frame: Up to 6 months

Secondary Outcomes

Change in insulin resistance
time frame: Up to 6 months

Eligibility Criteria

Female participants from 18 years up to 38 years old.

Inclusion Criteria: - Patients aged greater than 18 years of age - Ability to understand and willingness to comply with the study protocol - Written informed consent - Patients meeting the Rotterdam PCOS workshop criteria for polycystic ovary syndrome, defined by oligomenorrhea or amenorrhea and at least one of the following two signs: clinical or biochemical evidence of hyperandrogenism or ultrasound finding of polycystic appearing ovaries. Exclusion Criteria: - Current pregnancy or lactation - Liver disease or elevated liver enzymes - Established diagnosis of diabetes mellitus - Abnormal serum glucose levels either at fasting or after the 2-hr oral glucose tolerance test meeting criteria for the diagnosis of diabetes mellitus according to the American Diabetes Association. - Insulin sensitizing treatment within 3 months prior to or during the eight week study period. - Hormonal treatment involving estrogen or progesterone 3 months prior to or during the study period, with the exception of medroxyprogesterone acetate for withdrawal bleeding. - Systemic or inhaled corticosteroids. - Known hypersensitive reaction to cinnamon. - Patients with seizure disorders, known cardiovascular disease, or cerebrovascular disease. - Body mass index (BMI)range 20-50 (excluding all women with BMI under 20 or over 50).

Additional Information

Official title The Effects of Oral Cinnamon Extract on Menstrual Cyclicity in PolyCystic Ovary Syndrome
Principal investigator Rogerio Lobo, MD
Trial information was received from ClinicalTrials.gov and was last updated in July 2013.
Information provided to ClinicalTrials.gov by Columbia University.